Literature DB >> 11839852

Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls.

E K Tan1, S Y Lum, S M C Fook-Chong, M L Teoh, Y Yih, L Tan, A Tan, M C Wong.   

Abstract

The authors found a significantly higher prevalence of daytime somnolence in 201 patients with PD compared with 214 age- and sex-matched healthy control subjects (Epworth Sleepiness Scale score 5.6 vs 4.6). The prevalence of "sleep attacks" (SA) was about seven times higher in patients with PD than in control subjects (13.9% vs 1.9%; p < 0.0005). Multivariate analysis demonstrated that a higher dose of levodopa and longer duration of disease significantly predicted for SA in patients with PD. Epworth Sleepiness Scale scores of > or =10 had 71.4% sensitivity and 88.4% specificity for SA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839852     DOI: 10.1212/wnl.58.3.465

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.

Authors:  K R Chaudhuri; S Pal; A DiMarco; C Whately-Smith; K Bridgman; R Mathew; F R Pezzela; A Forbes; B Högl; C Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?

Authors:  Christian Baumann; Luigi Ferini-Strambi; Daniel Waldvogel; Esther Werth; Claudio Lino Bassetti
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

3.  Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.

Authors:  W G Ondo; R Fayle; F Atassi; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study.

Authors:  A Romigi; P Stanzione; M G Marciani; F Izzi; F Placidi; A Cervellino; P Giacomini; L Brusa; K Grossi; M Pierantozzi
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

5.  Sleepiness and Unintended Sleep in Parkinson's Disease.

Authors:  David B. Rye
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 6.  Parkinson's disease and sleep/wake disturbances.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Koichi Hirata
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

Review 7.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?

Authors:  K Ray Chaudhuri; Suvankar Pal; Christine Brefel-Courbon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.

Authors:  Joëlle Micallef; Marc Rey; Alexandre Eusebio; Christine Audebert; Frank Rouby; Elisabeth Jouve; Sophie Tardieu; Oliver Blin
Journal:  Br J Clin Pharmacol       Date:  2008-09-19       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.